"Today, the U.S. Food and Drug Administration approved Xuriden (uridine triacetate), the first FDA-approved treatment for patients with hereditary orotic aciduria. Hereditary orotic aciduria is a rare metabolic disorder, which has been reported in"...
Obtain information about your patient's medical history, current medications, any history of hypersensitivity to rocuronium bromide or other neuromuscular blocking agents. If applicable, inform your patients that certain medical conditions and medications might influence how ZEMURON works.
In addition, inform your patient that severe anaphylactic reactions to neuromuscular blocking agents, including ZEMURON, have been reported. Since allergic cross-reactivity has been reported in this class, request information from your patients about previous anaphylactic reactions to other neuromuscular blocking agents.
Last reviewed on RxList: 2/26/2015
This monograph has been modified to include the generic and brand name in many instances.
Additional Zemuron Information
Report Problems to the Food and Drug Administration
Find out what women really need.